MOUNTAIN VIEW, Calif., Jan. 24, 2013 /PRNewswire/ -- Medical Devices 2013: A Frost & Sullivan Executive MindXchange takes place March 10-12, 2013, at the Hilton San Diego Resort & Spa in San Diego, Calif. Participants will gain insight into the future of medical technology and healthcare delivery as they engage with other seasoned medical device executives driving the future of healthcare, as well as their company's innovation and business strategy.
Topics covered at this event include: Three Big Predictions: Healthcare 2025 – Personalization, Without PCP; Savvy Partnering for Innovation; Developing Innovative IP Strategies in a Global Economy; Mapping the Innovation Maturity Curve and mHealth: At the Forefront of Future Medicine. The valuable takeaways participants receive are very practical, and ready for immediate implementation.
"The Frost & Sullivan Executive MindXchange is one of the most uniquely designed and well thought out programs I have attended," said ConvaTec Global Government Affairs and Health Policy Vice President, Joseph Rolley. "The learning comes not just in the form of traditional lectures, but from audience participation and sharing of ideas and experiences."
The high-level program will be beneficial to senior-level executives, particularly those in C-level and vice president positions involved with; business development, government affairs & reimbursement, intellectual property, medical affairs, marketing, healthcare strategy, product development, QA, sales, strategic planning, technology assessment and commercialization, amongst others.
The influential keynote speakers at this event include:
Jim Hollingshead, Chief Strategy Officer and President of the Ventures and Initiatives Strategic Business Unit at ResMed, who will speak on mapping success in an outcomes-driven healthcare environment. The key takeaways provide insights into how outcomes-driven medicine influences go-to-market strategy for medical devices, leveraging medical research to inform and reset payer agendas, and creating compliance systems to align with personalized medicine.
Megan Moynahan, Assistant Director for Technology and Innovation from the Office of the Center Director at the Center for Devices and Radiological Health, (FDA) will address if the FDA can spur innovation. As stated by Moynahan, to handle truly innovative products against the vast tide of typical products it regulates, the FDA needs to cultivate both an "innovation mindset" and a "production mindset" – two opposing internal cultures that give rise to different processes and practices. The opposing cultures of "production" and "innovation" can co-exist in an organization, but only a thriving culture of innovation at the FDA will bring about the kind of transformative change needed to address long-standing trends.
Joe Kiani, Chairman and CEO at Masimo Corporation, will speak to the mounting cost pressures and rising healthcare inflation. According to Kiani, there is a recipe for "doing the right thing," which can protect patients, fuel innovation and reduce costs in our healthcare system.
Additional event highlights include "The Vino Voyage," where executive attendees will get acquainted over a wine tasting luncheon while cruising the San Diego harbor. Attendees will participate in a unique event format of two-way dialogue and debate, while taking in the breathtaking location. Just seven miles from downtown, the Hilton San Diego Hotel sits on 18 acres of recreational paradise. The hotel also boasts an award-winning executive Chef and banquet team.
Click here to register for Medical Devices 2013 or visit: www.frost.com/dev. For more information, please email: email@example.com. Also, feel free to join the conversation on Twitter through #DEV13.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.
Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Corporate Communications – North America
SOURCE Frost & Sullivan